The Constitutively Active PKG II Mutant Effectively Inhibits Gastric Cancer Development a Blockade of EGF/EGFR-associated Signalling Cascades

Overview

Journal Ther Adv Med Oncol

Specialty Oncology

Date 2018 Feb 14

PMID 29434677

Citations 8

Authors

Yan Wu

Miaomiao Yuan

Wenbin Su

Miaolin Zhu

Xiaoyuan Yao

Ying Wang

Hai Qian

Lu Jiang

Yan Tao

Min Wu

Ji Pang

Yongchang Chen

Affiliations

Soon will be listed here.

Abstract

Type II cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG II) is a membrane-anchored enzyme expressed mainly in the intestinal mucosa and the brain, and is associated with various physiological or pathological processes. Upregulation of PKG II is known to induce apoptosis and inhibit proliferation and metastasis of cancer cells. The inhibitory effect of PKG II has been shown to be dependent on the inhibition of the activation of epidermal growth factor receptor (EGFR) and blockade of EGFR downstream signal transduction However, it remains unclear whether similar phenomena/mechanisms exist and whether these effects are independent of cGMP or cGMP analogues. In the present work, nude mice with transplanted orthotopic tumours were infected with adenovirus encoding cDNA of constitutively active PKG II mutant (Ad-a-PKG II) and the effect of constitutively active PKG II (a-PKG II) on tumour development was detected. The results showed that a-PKG II effectively ameliorated gastric tumour development through delaying the growth, inducing the apoptosis, and inhibiting the metastasis and angiogenesis. The effect was related to blockade of EGFR activation and abrogation of the downstream signalling cascades. These findings provide novel insight which will benefit the development of new cancer therapies.

Citing Articles

Recent advances in the role of gasotransmitters in necroptosis.

Hao M, Li H, Han H, Chu T, Wang Y, Si W Apoptosis. 2025; .

PMID: 39833633 DOI: 10.1007/s10495-024-02057-x.

Unveiling the shared genes between systemic sclerosis and lung cancer.

Pan P, Liu X, Wang Y, Wang H, Xu C, Lu J Front Med (Lausanne). 2025; 11:1431642.

PMID: 39744538 PMC: 11688373. DOI: 10.3389/fmed.2024.1431642.

Oncolytic virus: A catalyst for the treatment of gastric cancer.

Wang J, Du L, Chen X Front Oncol. 2022; 12:1017692.

PMID: 36505792 PMC: 9731121. DOI: 10.3389/fonc.2022.1017692.

Helicid Reverses the Effect of Overexpressing , Which Blocks the sGC/cGMP/PKG Signaling Pathway in the CUMS-Induced Rat Model.

Zhang X, Zhang Y, Zhang Y, Jiang Z, Yang H, Jiang L J Healthc Eng. 2021; 2021:7168397.

PMID: 34931140 PMC: 8684516. DOI: 10.1155/2021/7168397.

New In Vitro Cellular Model for Molecular Studies of Retinitis Pigmentosa.

Huang L, Kutluer M, Adani E, Comitato A, Marigo V Int J Mol Sci. 2021; 22(12).

PMID: 34208617 PMC: 8235468. DOI: 10.3390/ijms22126440.

References

Karami-Tehrani F, Fallahian F, Atri M . Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors. Tumour Biol. 2012; 33(6):1927-32. DOI: 10.1007/s13277-012-0453-9. View

Lee K, Piazza G . The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer. J Biomed Res. 2017; 31(3):189-196. PMC: 5460607. DOI: 10.7555/JBR.31.20160133. View

Tomas A, Futter C, Eden E . EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol. 2013; 24(1):26-34. PMC: 3884125. DOI: 10.1016/j.tcb.2013.11.002. View

Swartling F, Ferletta M, Kastemar M, Weiss W, Westermark B . Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene. 2009; 28(35):3121-31. PMC: 3030987. DOI: 10.1038/onc.2009.168. View

Deguchi A, Thompson W, Weinstein I . Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res. 2004; 64(11):3966-73. DOI: 10.1158/0008-5472.CAN-03-3740. View

Rainer P, Kass D . Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G. Cardiovasc Res. 2016; 111(2):154-62. PMC: 4937204. DOI: 10.1093/cvr/cvw107. View

Jiang L, Wu M, Wu Y, Lan T, Wang Y, Qian H . Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines. Oncol Lett. 2015; 9(6):2781-2786. PMC: 4473676. DOI: 10.3892/ol.2015.3067. View

Wu Y, Chen Y, Qu R, Lan T, Sang J . Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Oncol Rep. 2011; 27(2):553-8. DOI: 10.3892/or.2011.1507. View

Ceresa B, Peterson J . Cell and molecular biology of epidermal growth factor receptor. Int Rev Cell Mol Biol. 2014; 313:145-78. DOI: 10.1016/B978-0-12-800177-6.00005-0. View

10.

Wang T, Zhang X, Guo X, Xian S, Lu Y . 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth. Oncol Rep. 2015; 35(3):1287-96. PMC: 4750747. DOI: 10.3892/or.2015.4511. View

11.

Krejci P, Masri B, Fontaine V, Mekikian P, Weis M, Prats H . Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 2005; 118(Pt 21):5089-100. DOI: 10.1242/jcs.02618. View

12.

Wu M, Wu Y, Lan T, Jiang L, Qian H, Chen Y . Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells. Mol Med Rep. 2016; 14(2):1849-56. DOI: 10.3892/mmr.2016.5452. View

13.

Lee K, Lindsey A, Li N, Gary B, Andrews J, Keeton A . β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG. Oncotarget. 2015; 7(5):5353-65. PMC: 4868691. DOI: 10.18632/oncotarget.6705. View

14.

Li N, Chen X, Zhu B, Ramirez-Alcantara V, Canzoneri J, Lee K . Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10. Oncotarget. 2015; 6(29):27403-15. PMC: 4694998. DOI: 10.18632/oncotarget.4741. View

15.

Vaandrager A, Hogema B, De Jonge H . Molecular properties and biological functions of cGMP-dependent protein kinase II. Front Biosci. 2005; 10:2150-64. DOI: 10.2741/1687. View

16.

Hofmann F, Feil R, Kleppisch T, Schlossmann J . Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev. 2005; 86(1):1-23. DOI: 10.1152/physrev.00015.2005. View

17.

Jurikova M, Danihel L, Polak S, Varga I . Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 2016; 118(5):544-52. DOI: 10.1016/j.acthis.2016.05.002. View

18.

Gambaryan S, Palmetshofer A, Glazova M, Smolenski A, Kristjansson G, Zimmer M . Inhibition of cGMP-dependent protein kinase II by its own splice isoform. Biochem Biophys Res Commun. 2002; 293(5):1438-44. DOI: 10.1016/S0006-291X(02)00412-6. View

19.

Smolenski A, Poller W, Walter U, Lohmann S . Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J Biol Chem. 2000; 275(33):25723-32. DOI: 10.1074/jbc.M909632199. View

20.

Fallahian F, Karami-Tehrani F, Salami S . Induction of apoptosis by type Iβ protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468. Cell Biochem Funct. 2011; 30(3):183-90. DOI: 10.1002/cbf.1831. View